Modified FOLFIRINOX versus S-1 as second-line chemotherapy in patients with gemcitabine-failed metastatic pancreatic cancer: A randomized phase III trial (MPACA-3).
Citations

WEB OF SCIENCE

1
제목
Modified FOLFIRINOX versus S-1 as second-line chemotherapy in patients with gemcitabine-failed metastatic pancreatic cancer: A randomized phase III trial (MPACA-3).
저자
Go, Se-IlLee, Sang-CheolBae, Woo KyunZang, Dae YoungLee, Hyun WooJang, Joung SoonJi, Jun HoKim, Jung HoonPark, SanggonSym, Sun JinYang, YaewonJeon, So YeonOh, Sung YongKang, Jung Hun
DOI
10.1200/JCO.2021.39.15_suppl.4119
발행일
2021-05-20
유형
Meeting Abstract
저널명
Journal of Clinical Oncology
39
15